O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.82B
AUM Growth
-$649M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
132
New
Increased
Reduced
Closed

Top Buys

1
+$93.6M
2
+$86.8M
3
+$84.8M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$38.9M
5
CYTK icon
Cytokinetics
CYTK
+$38.4M

Top Sells

1
+$81.3M
2
+$55.2M
3
+$48.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$47.5M
5
EVH icon
Evolent Health
EVH
+$47.1M

Sector Composition

1 Healthcare 98.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$6.53M 0.13%
+94,559
77
$6.12M 0.13%
+920,339
78
$5.8M 0.12%
294,947
79
$5.61M 0.12%
2,133,405
80
$5.38M 0.11%
605,531
81
$5.34M 0.11%
921,959
-501,511
82
$5.23M 0.11%
237,784
83
$5.2M 0.11%
298,301
+26,391
84
$4.72M 0.1%
2,000,000
85
$4.35M 0.09%
3,322,488
86
$4.2M 0.09%
370,243
-120,901
87
$3.68M 0.08%
23,500
88
$3.52M 0.07%
206,000
89
$3.15M 0.06%
435,318
90
$2.91M 0.06%
+112,500
91
$2.77M 0.06%
1,680,580
92
$2.47M 0.05%
653,016
-144,342
93
$2.23M 0.05%
116,785
+83,085
94
$2.05M 0.04%
821,400
-659,200
95
$1.99M 0.04%
155,181
-149,119
96
$1.94M 0.04%
+78,500
97
$1.84M 0.04%
+66,000
98
$1.7M 0.04%
+550,000
99
$1.54M 0.03%
3,099,265
100
$1.32M 0.03%
+348,000
2 3
4
5 6